Cargando…

miR-654-3p suppresses cell viability and promotes apoptosis by targeting RASAL2 in non-small-cell lung cancer

Non-small-cell lung cancer (NSCLC) accounts for 80% of lung cancer cases, and is the leading cause of cancer-associated mortality worldwide. The present study aimed to investigate the roles of microRNA (miR)-654-3p in NSCLC. The expression levels of miR-654-3p and its target ras protein activator li...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Jie, Xing, Shigang, Dong, Zheng, Niu, Lei, Xu, Qinghua, Li, Yusheng, Liu, Pingyi, Yang, Peixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751472/
https://www.ncbi.nlm.nih.gov/pubmed/33300072
http://dx.doi.org/10.3892/mmr.2020.11763
_version_ 1783625674223779840
author Xiong, Jie
Xing, Shigang
Dong, Zheng
Niu, Lei
Xu, Qinghua
Li, Yusheng
Liu, Pingyi
Yang, Peixia
author_facet Xiong, Jie
Xing, Shigang
Dong, Zheng
Niu, Lei
Xu, Qinghua
Li, Yusheng
Liu, Pingyi
Yang, Peixia
author_sort Xiong, Jie
collection PubMed
description Non-small-cell lung cancer (NSCLC) accounts for 80% of lung cancer cases, and is the leading cause of cancer-associated mortality worldwide. The present study aimed to investigate the roles of microRNA (miR)-654-3p in NSCLC. The expression levels of miR-654-3p and its target ras protein activator like 2 (RASAL2) mRNA were determined by reverse transcription-quantitative polymerase chain reaction; protein expression was analyzed by western blotting. Plasmids expressing miR-654-3p mimics were constructed and transfected into A549 cells. In addition, the viability and apoptotic rate of cells were analyzed by an MTT assay and flow cytometry, respectively. A luciferase reporter assay was performed to verify whether RASAL2 is a target of miR-654-3p. Downregulated miR-654-3p and upregulated RASAL2 expression were observed in tumor tissues and cells. Cell viability was suppressed and the apoptotic rate was increased in the miR-654-3p mimics-transfected cells compared with the control. Luciferase activity was decreased in the RASAL2-3′ untranslated region-wild type group treated with miR-654-3p mimics. Furthermore, the present study revealed that overexpression of miR-654-3p could suppress the viability and induce the apoptosis of cells by targeting RASAL2 in NSCLC. The present findings may contribute to developments in the treatment of NSCLC.
format Online
Article
Text
id pubmed-7751472
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-77514722020-12-28 miR-654-3p suppresses cell viability and promotes apoptosis by targeting RASAL2 in non-small-cell lung cancer Xiong, Jie Xing, Shigang Dong, Zheng Niu, Lei Xu, Qinghua Li, Yusheng Liu, Pingyi Yang, Peixia Mol Med Rep Articles Non-small-cell lung cancer (NSCLC) accounts for 80% of lung cancer cases, and is the leading cause of cancer-associated mortality worldwide. The present study aimed to investigate the roles of microRNA (miR)-654-3p in NSCLC. The expression levels of miR-654-3p and its target ras protein activator like 2 (RASAL2) mRNA were determined by reverse transcription-quantitative polymerase chain reaction; protein expression was analyzed by western blotting. Plasmids expressing miR-654-3p mimics were constructed and transfected into A549 cells. In addition, the viability and apoptotic rate of cells were analyzed by an MTT assay and flow cytometry, respectively. A luciferase reporter assay was performed to verify whether RASAL2 is a target of miR-654-3p. Downregulated miR-654-3p and upregulated RASAL2 expression were observed in tumor tissues and cells. Cell viability was suppressed and the apoptotic rate was increased in the miR-654-3p mimics-transfected cells compared with the control. Luciferase activity was decreased in the RASAL2-3′ untranslated region-wild type group treated with miR-654-3p mimics. Furthermore, the present study revealed that overexpression of miR-654-3p could suppress the viability and induce the apoptosis of cells by targeting RASAL2 in NSCLC. The present findings may contribute to developments in the treatment of NSCLC. D.A. Spandidos 2021-02 2020-12-08 /pmc/articles/PMC7751472/ /pubmed/33300072 http://dx.doi.org/10.3892/mmr.2020.11763 Text en Copyright: © Xiong et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Xiong, Jie
Xing, Shigang
Dong, Zheng
Niu, Lei
Xu, Qinghua
Li, Yusheng
Liu, Pingyi
Yang, Peixia
miR-654-3p suppresses cell viability and promotes apoptosis by targeting RASAL2 in non-small-cell lung cancer
title miR-654-3p suppresses cell viability and promotes apoptosis by targeting RASAL2 in non-small-cell lung cancer
title_full miR-654-3p suppresses cell viability and promotes apoptosis by targeting RASAL2 in non-small-cell lung cancer
title_fullStr miR-654-3p suppresses cell viability and promotes apoptosis by targeting RASAL2 in non-small-cell lung cancer
title_full_unstemmed miR-654-3p suppresses cell viability and promotes apoptosis by targeting RASAL2 in non-small-cell lung cancer
title_short miR-654-3p suppresses cell viability and promotes apoptosis by targeting RASAL2 in non-small-cell lung cancer
title_sort mir-654-3p suppresses cell viability and promotes apoptosis by targeting rasal2 in non-small-cell lung cancer
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751472/
https://www.ncbi.nlm.nih.gov/pubmed/33300072
http://dx.doi.org/10.3892/mmr.2020.11763
work_keys_str_mv AT xiongjie mir6543psuppressescellviabilityandpromotesapoptosisbytargetingrasal2innonsmallcelllungcancer
AT xingshigang mir6543psuppressescellviabilityandpromotesapoptosisbytargetingrasal2innonsmallcelllungcancer
AT dongzheng mir6543psuppressescellviabilityandpromotesapoptosisbytargetingrasal2innonsmallcelllungcancer
AT niulei mir6543psuppressescellviabilityandpromotesapoptosisbytargetingrasal2innonsmallcelllungcancer
AT xuqinghua mir6543psuppressescellviabilityandpromotesapoptosisbytargetingrasal2innonsmallcelllungcancer
AT liyusheng mir6543psuppressescellviabilityandpromotesapoptosisbytargetingrasal2innonsmallcelllungcancer
AT liupingyi mir6543psuppressescellviabilityandpromotesapoptosisbytargetingrasal2innonsmallcelllungcancer
AT yangpeixia mir6543psuppressescellviabilityandpromotesapoptosisbytargetingrasal2innonsmallcelllungcancer